tradingkey.logo
tradingkey.logo
Search

Perspective Therapeutics Inc

CATX
Add to Watchlist
2.500USD
-0.120-4.58%
Close 09-24 16:00(ET)
285.13MMarket Cap
LossP/E TTM
After-hours 18:30 (ET)2.500USD+0.005+0.20%

CATX Financials

See Perspective Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Key Financial Ratios

Market Cap
285.13M
Dividend TTM
0.00
P/E TTM
-1.78
EPS TTM
-1.40
Revenue
884.00K
Net Profit
-79.28M
ROE
-35.33%
ROA
-30.17%

Perspective Therapeutics Inc Earnings Date

Latest Release
Aug 10, 2026
EPS / Forecast
-0.22/-0.26
Revenue / Forecast
81.00K/83.15K

Financial Statement Highlights

Quarterly
Quarterly+Annual
Quarterly
Annual
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
23.29%-0.22
-0.62%-0.25
11.09%-0.50
-63.26%-0.35
-64.81%-0.29
-1.25%-0.25
---0.57
41.99%-0.21
55.73%-0.18
-1431.48%-0.25
----
---0.37
---0.40
---0.02
---0.23
----
----
----
----
----
----
Revenue
-72.07%81.00K
-77.78%76.00K
-81.62%43.00K
-43.36%209.00K
-44.87%290.00K
5.23%342.00K
--234.00K
-83.11%369.00K
-74.81%526.00K
-84.25%325.00K
----
-24.91%2.19M
-25.85%2.09M
-19.54%2.06M
-32.29%1.83M
11.92%2.91M
19.37%2.82M
7.55%2.56M
18.91%2.71M
-9.72%2.60M
6.94%2.36M
Net Profit
-24.67%-26.79M
-44.08%-26.19M
6.67%-37.49M
-71.73%-25.97M
-83.57%-21.48M
-47.97%-18.18M
---40.17M
-46.02%-15.12M
-5.38%-11.70M
-3211.05%-12.28M
----
-668.82%-10.36M
-592.39%-11.11M
83.46%-371.00K
-207.92%-3.27M
-80.81%-1.35M
-84.79%-1.60M
-213.27%-2.24M
10.92%-1.06M
-35.95%-745.00K
3.45%-868.00K
Net Margin
-339.14%-33312.35%
-548.35%-34459.21%
-407.89%-87186.05%
-203.20%-12425.36%
-255.82%-7585.86%
-46.08%-5314.91%
---17166.24%
-764.65%-4098.10%
-300.82%-2131.94%
-20132.20%-3638.46%
----
---473.96%
---531.90%
---17.98%
---178.04%
----
----
----
----
----
----
Gross Margin
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
--100.00%
196.07%100.00%
741.94%100.00%
323.61%100.00%
----
--33.78%
--11.88%
--23.61%
--21.96%
----
----
----
----
----
----
Debt to assets ratio
-23.33%0.41%
-22.42%0.39%
23.81%0.61%
28.67%0.56%
20.27%0.53%
-17.92%0.51%
-72.10%0.49%
-72.53%0.43%
-70.05%0.44%
-56.18%0.62%
--1.76%
--1.57%
--1.47%
--1.40%
----
----
----
----
----
----
----
Revenue
-72.07%81.00K
-77.78%76.00K
-81.62%43.00K
-43.36%209.00K
-44.87%290.00K
5.23%342.00K
--234.00K
-83.11%369.00K
-74.81%526.00K
-84.25%325.00K
----
-24.91%2.19M
-25.85%2.09M
-19.54%2.06M
-32.29%1.83M
11.92%2.91M
19.37%2.82M
7.55%2.56M
18.91%2.71M
-9.72%2.60M
6.94%2.36M
Operating profit
-21.71%-29.26M
-29.54%-28.28M
-90.63%-39.83M
-49.52%-27.86M
-68.54%-24.04M
-67.87%-21.83M
---20.89M
-76.89%-18.63M
-25.40%-14.26M
-16.06%-13.01M
----
-665.55%-10.53M
-595.66%-11.37M
-392.74%-11.21M
-209.52%-3.38M
-80.10%-1.38M
-88.80%-1.64M
-218.49%-2.27M
8.07%-1.09M
-39.42%-764.00K
4.10%-866.00K
Net Profit
-24.67%-26.79M
-44.08%-26.19M
6.67%-37.49M
-71.73%-25.97M
-83.57%-21.48M
-47.97%-18.18M
---40.17M
-46.02%-15.12M
-5.38%-11.70M
-3211.05%-12.28M
----
-668.82%-10.36M
-592.39%-11.11M
83.46%-371.00K
-207.92%-3.27M
-80.81%-1.35M
-84.79%-1.60M
-213.27%-2.24M
10.92%-1.06M
-35.95%-745.00K
3.45%-868.00K
Current assets
23.25%241.52M
27.63%275.35M
-35.81%148.39M
-33.93%178.50M
-33.40%195.96M
14.63%215.74M
1272.93%231.16M
1145.72%270.17M
820.81%294.24M
367.39%188.20M
-68.36%16.84M
-65.44%21.69M
-49.76%31.95M
-38.01%40.27M
-20.93%53.22M
-7.81%62.76M
417.57%63.60M
1268.69%64.96M
1122.12%67.30M
1090.31%68.07M
----
Total current liabilities
181.41%36.54M
148.33%31.49M
57.32%28.68M
-26.74%20.62M
22.39%12.99M
-12.58%12.68M
16.38%18.23M
246.80%28.14M
23.53%10.61M
101.60%14.50M
485.35%15.66M
314.88%8.12M
365.53%8.59M
299.89%7.19M
48.58%2.68M
2.09%1.96M
38.20%1.84M
18.20%1.80M
14.35%1.80M
9.86%1.92M
----
Total assets
26.16%392.02M
24.72%410.77M
-21.73%266.97M
-24.63%294.82M
-19.48%310.73M
18.35%329.35M
248.45%341.10M
253.93%391.15M
221.21%385.92M
118.02%278.29M
68.51%97.89M
67.17%110.52M
78.65%120.14M
85.77%127.64M
-17.50%58.09M
-7.25%66.11M
333.52%67.25M
756.20%68.71M
709.47%70.42M
695.36%71.28M
----
Total liabilities
51.36%68.16M
41.67%63.33M
18.85%59.94M
-16.07%52.61M
0.25%45.03M
-7.63%44.70M
122.05%50.43M
433.55%62.68M
290.90%44.92M
403.22%48.40M
558.51%22.71M
303.43%11.75M
301.68%11.49M
225.89%9.62M
14.58%3.45M
-8.49%2.91M
4.42%2.86M
0.72%2.95M
1.14%3.01M
1.21%3.18M
----
Total equity
21.89%323.86M
22.06%347.44M
-28.77%207.03M
-26.26%242.22M
-22.08%265.69M
23.82%284.64M
286.63%290.67M
232.56%328.47M
213.84%341.00M
94.78%229.89M
37.58%75.18M
56.28%98.77M
68.74%108.65M
79.49%118.03M
-18.94%54.64M
-7.19%63.20M
404.12%64.39M
1190.66%65.76M
1077.81%67.41M
1070.47%68.10M
----
Net operating income
-3.49%-20.65M
-45.81%-31.47M
7.33%-24.66M
-584.02%-16.29M
-124.14%-19.95M
-255.85%-21.58M
-195.36%-26.61M
133.29%3.37M
-10.28%-8.90M
242.43%13.85M
-108.37%-9.01M
-610.97%-10.11M
-514.78%-8.07M
-366.55%-9.72M
-286.67%-4.32M
-128.99%-1.42M
-72.76%-1.31M
-516.57%-2.08M
-31.84%-1.12M
27.96%-621.00K
----
Net investment
252.23%15.02M
-1868.61%-109.55M
120.59%28.54M
147.05%13.99M
229.41%4.26M
88.23%-5.56M
-155632.58%-138.60M
-13000.00%-29.74M
-475.04%-3.29M
-287.23%-47.30M
-101.41%-89.00K
-773.08%-227.00K
-607.41%-573.00K
46881.48%25.26M
4684.78%6.33M
73.74%-26.00K
-35.00%-81.00K
52.21%-54.00K
-253.85%-138.00K
-125.00%-99.00K
----
Net financing
11.36%147.00K
1548.09%164.36M
-103.77%-13.00K
-66.08%213.00K
-99.89%132.00K
-94.00%9.97M
-1.99%345.00K
62700.00%628.00K
23744.53%122.08M
208010.00%166.33M
--352.00K
--1.00K
814.29%512.00K
---80.00K
-100.00%0.00
-100.00%0.00
-99.34%56.00K
----
-72.20%243.00K
42629.77%55.98M
----

Revenue

By Business

Period:
No Data

By Region

Period:
No Data

FAQs

What is the total revenue of Perspective Therapeutics Inc?

According to Perspective Therapeutics Inc's FY2025 earnings report, its total revenue reached 884.00K, with a year-on-year change of 1.45M.

What are the current assets of Perspective Therapeutics Inc?

According to Perspective Therapeutics Inc's FY2025 earnings report, its current assets were 148.39M, with a year-on-year change of -35.81.

What are the total assets of Perspective Therapeutics Inc?

According to Perspective Therapeutics Inc's FY2025 earnings report, its total assets of Perspective Therapeutics Inc were 266.97M, with a year-on-year change of -21.73.

What are the total liabilities of Perspective Therapeutics Inc?

According to Perspective Therapeutics Inc's FY2025 earnings report, its total liabilities of Perspective Therapeutics Inc were 59.94M, with a year-on-year change of 18.85.

What is the total equity of Perspective Therapeutics Inc?

According to Perspective Therapeutics Inc's FY2025 earnings report, its total equity of Perspective Therapeutics Inc was 207.03M, with a year-on-year change of -28.77.

What is the net operating income of Perspective Therapeutics Inc?

According to Perspective Therapeutics Inc's FY2025 earnings report, its net operating income of Perspective Therapeutics Inc was -113.56M, with a year-on-year change of -70.01.

What is the net investment of Perspective Therapeutics Inc?

According to Perspective Therapeutics Inc's FY2025 earnings report, its net investment of Perspective Therapeutics Inc was 41.23M, with a year-on-year change of 118.83.

What is the net financing of Perspective Therapeutics Inc?

According to Perspective Therapeutics Inc's FY2025 earnings report, its net financing of Perspective Therapeutics Inc was 10.30M, with a year-on-year change of -96.44.

What is the Earnings Per Share (EPS) of Perspective Therapeutics Inc?

According to Perspective Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -1.40, with a year-on-year change of -13.53.

What is the net income of Perspective Therapeutics Inc?

According to Perspective Therapeutics Inc's FY2025 earnings report, its net income was -103.12M, with a year-on-year change of -30.07.

What is the net margin of Perspective Therapeutics Inc?

According to Perspective Therapeutics Inc's FY2025 earnings report, its net profit margin was -11723.42, with a year-on-year change of -117.62.

What is the debt-to-asset ratio of Perspective Therapeutics Inc?

According to Perspective Therapeutics Inc's FY2025 earnings report, its debt-to-asset ratio was 0.61, with a year-on-year change of 23.81.

What is the Return on Equity (ROE) of Perspective Therapeutics Inc?

According to Perspective Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -41.65, with a year-on-year change of 2.75.

What is the Return on Assets (ROA) of Perspective Therapeutics Inc?

According to Perspective Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -34.09, with a year-on-year change of 4.48.

What is the operating profit of Perspective Therapeutics Inc?

According to Perspective Therapeutics Inc's FY2025 earnings report, its operating profit was -113.56M, with a year-on-year change of -70.01.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.